402 related articles for article (PubMed ID: 21484786)
1. ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma.
Jovanovic I; Radosavljevic G; Mitrovic M; Juranic VL; McKenzie AN; Arsenijevic N; Jonjic S; Lukic ML
Eur J Immunol; 2011 Jul; 41(7):1902-12. PubMed ID: 21484786
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
3. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.
Milovanovic M; Volarevic V; Ljujic B; Radosavljevic G; Jovanovic I; Arsenijevic N; Lukic ML
PLoS One; 2012; 7(9):e45225. PubMed ID: 23028861
[TBL] [Abstract][Full Text] [Related]
4. IL-33/ST2 axis in inflammation and immunopathology.
Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
[TBL] [Abstract][Full Text] [Related]
5. IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis.
Babic ZM; Zunic FZ; Pantic JM; Radosavljevic GD; Jovanovic IP; Arsenijevic NN; Lukic ML
J Biomed Sci; 2018 Jul; 25(1):56. PubMed ID: 30001716
[TBL] [Abstract][Full Text] [Related]
6. CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses.
Vinay DS; Choi BK; Bae JS; Kim WY; Gebhardt BM; Kwon BS
J Immunol; 2004 Sep; 173(6):4218-29. PubMed ID: 15356173
[TBL] [Abstract][Full Text] [Related]
7. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice.
Zhao J; Zhang H; Liu SB; Han P; Hu S; Li Q; Wang ZF; Mao-Ying QL; Chen HM; Jiang JW; Wu GC; Mi WL; Wang YQ
Neuroscience; 2013 Dec; 253():172-82. PubMed ID: 23988433
[TBL] [Abstract][Full Text] [Related]
8. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma.
Ma HL; Whitters MJ; Konz RF; Senices M; Young DA; Grusby MJ; Collins M; Dunussi-Joannopoulos K
J Immunol; 2003 Jul; 171(2):608-15. PubMed ID: 12847225
[TBL] [Abstract][Full Text] [Related]
9. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity.
Kasaian MT; Whitters MJ; Carter LL; Lowe LD; Jussif JM; Deng B; Johnson KA; Witek JS; Senices M; Konz RF; Wurster AL; Donaldson DD; Collins M; Young DA; Grusby MJ
Immunity; 2002 Apr; 16(4):559-69. PubMed ID: 11970879
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii.
Ferreira LS; Portuondo DL; Polesi MC; Carlos IZ
Immunology; 2018 Dec; 155(4):467-476. PubMed ID: 30030839
[TBL] [Abstract][Full Text] [Related]
11. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
[TBL] [Abstract][Full Text] [Related]
12. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.
Kim HY; Chang YJ; Subramanian S; Lee HH; Albacker LA; Matangkasombut P; Savage PB; McKenzie AN; Smith DE; Rottman JB; DeKruyff RH; Umetsu DT
J Allergy Clin Immunol; 2012 Jan; 129(1):216-27.e1-6. PubMed ID: 22119406
[TBL] [Abstract][Full Text] [Related]
13. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
Zeng S; Wu J; Liu J; Qi F; Liu B
Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
[TBL] [Abstract][Full Text] [Related]
14. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.
Smithgall MD; Comeau MR; Yoon BR; Kaufman D; Armitage R; Smith DE
Int Immunol; 2008 Aug; 20(8):1019-30. PubMed ID: 18550585
[TBL] [Abstract][Full Text] [Related]
15. Dual blockage of PD-L/PD-1 and IL33/ST2 axes slows tumor growth and improves antitumor immunity by boosting NK cells.
Jovanovic MZ; Geller DA; Gajovic NM; Jurisevic MM; Arsenijevic NN; Jovanovic MM; Supic GM; Vojvodic DV; Jovanovic IP
Life Sci; 2022 Jan; 289():120214. PubMed ID: 34890591
[TBL] [Abstract][Full Text] [Related]
16. IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice.
Di Carlo E; Comes A; Orengo AM; Rosso O; Meazza R; Musiani P; Colombo MP; Ferrini S
J Immunol; 2004 Feb; 172(3):1540-7. PubMed ID: 14734732
[TBL] [Abstract][Full Text] [Related]
17. In vivo acute depletion of CD8(+) T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells.
Salem ML; Hossain MS
Int J Immunopharmacol; 2000 Sep; 22(9):707-18. PubMed ID: 10884591
[TBL] [Abstract][Full Text] [Related]
18. ST2 deletion increases inflammatory bone destruction in experimentally induced periapical lesions in mice.
Velickovic M; Pejnovic N; Mitrovic S; Radosavljevic G; Jovanovic I; Kanjevac T; Jovicic N; Lukic A
J Endod; 2015 Mar; 41(3):369-75. PubMed ID: 25595464
[TBL] [Abstract][Full Text] [Related]
19. The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis.
Sesti-Costa R; Silva GK; Proença-Módena JL; Carlos D; Silva ML; Alves-Filho JC; Arruda E; Liew FY; Silva JS
J Immunol; 2013 Jul; 191(1):283-92. PubMed ID: 23733876
[TBL] [Abstract][Full Text] [Related]
20. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
